title: How should I treat a restenosis after superficial femoral artery stenting?
authors.affiliation: Deutsches Herzzentrum, Technische Universität, Munich, Germany. fusaro@dhm.mhn.de
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Fusaro
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cassese
authors.forename: Robert A
authors.initials: RA
authors.lastname: Byrne
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon / Q000009:adverse effects* / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D020099:Coated Materials, Biocompatible; D003251:Constriction, Pathologic; D004867:Equipment Design; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000628:therapy*; D011237:Predictive Value of Tests; D012008:Recurrence; D015607:Stents; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D062666:Vascular Access Devices
chemical_list: D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel